• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    5.95 Down 0.38(6.00%) 4:00PM EDT
    Add to Portfolio
    Prev Close:6.33
    Open:6.33
    Bid:5.95 x 1000
    Ask:7.66 x 500
    1y Target Est:10.50
    Beta:-0.251344
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:5.87 - 6.45
    52wk Range:4.00 - 13.58
    Volume:381,217
    Avg Vol (3m):764,825
    Market Cap:176.25M
    P/E (ttm):N/A
    EPS (ttm):-1.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):646.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.31
    Quarterly EPS Est (Sep-15) :-0.28
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback